Clinical Trial: A Study to Learn About How BAY 3283142 Moves Into, Through, and Out of the Body After a Single Dose in Participants With Reduced Liver Function Compared to Participants With Normal Liver Function
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Chronic Kidney Disease
Study Type: INTERVENTIONAL
Official Title: An Open-label Study to Evaluate the Pharmacokinetics, Safety and Tolerability of BAY 3283142 in Participants With Impaired Hepatic Function (Classified as Child-Pugh A or B) in Comparison to Matched C
Brief Summary:
Researchers are looking for a better way to treat people who have chronic kidney disease (CKD).CKD is a condition in which the kidneys' ability to work properly gradually decreases over time.The kidneys help the body get rid of waste through urine and filter the blood before sending it back to the heart.When kidney function decreases, waste builds up in the body, which can cause various complications.The study treatment, BAY 3283142, is under development to treat CKD.It works by activating a protein called…
Read more